Today's Edition
A. SREENIVASA REDDY (ABU DHABI)
A wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) has entered into a definitive agreement to invest $200 million for a 3% stake in Micro Life Sciences Private Limited (Meril), one of India’s leading medical devices companies. This investment, which values Meril at an enterprise value of $6.6 billion, was confirmed in separate statements issued by both ADIA and Meril.
The transaction is subject to regulatory approval by India’s Competition Commission. Once completed, it will result in Meril being backed by two globally recognised investors: ADIA and Warburg Pincus.
Founded by the Bilakhia Group, Meril is headquartered in Vapi, in Gujarat province of India, and is a global innovator in the medical technology space. The company focuses on clinically advanced solutions across key healthcare domains, including cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics, and surgical robotics.
Meril’s operations span more than 150 countries and are supported by a network of 35+ global subsidiaries. Its vertically integrated and globally certified manufacturing and research facilities are spread across a 100-acre sustainable MedTech campus. Employing over 13,000 people, Meril powers its operations entirely with green energy and runs more than 12 global training academies that reach over 10,000 healthcare professionals annually.
Notable product innovations include the Myval Transcatheter Heart Valve (THV) series, the MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System. The company holds a portfolio of over 200 technology platforms and maintains a strong in-house ecosystem for global research, clinical trials, and education.
Commenting on the deal, Sanjeev Bhatt, Senior Vice President – Strategy at Meril, said, “This investment by ADIA reinforces confidence in Meril’s long-term vision and global ambitions. This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our RCD and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.”
Established in 1976, ADIA is a globally diversified investment institution that prudently invests funds on behalf of the Government of Abu Dhabi through a strategy focused on long‑term value creation.
